Cystic fibrosis lung

3 trials MedDRA PT
3 Registered trials
0 Recruiting
2 Unique sponsors
3 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
V Various (ATC V) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Phase II: 1 Phase I/II: 1 Phase I (First in Human): 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II

1 trial
  • Arcturus Therapeutics Europe B.V. Commercial
    MRNA ENCODING THE HUMAN CFTR GENE
    2024-517663-23-01 2 countries n=10 Orphan
    Ended

Phase I/II

1 trial
  • Boehringer Ingelheim International GmbH Commercial
    BI 3720931
    2023-504909-37-00 4 countries 2025 n=12
    Ended

Phase I (First in Human)

1 trial
  • Boehringer Ingelheim International GmbH Commercial
    BI 3720931; GADOBUTROL
    2023-503281-23-00 4 countries 2024 n=12
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Boehringer Ingelheim International GmbH Commercial 2 Phase I (First in Human), Phase I/II 0
Arcturus Therapeutics Europe B.V. Commercial 1 Phase II 0
New trials by year
2024
1
2025
1
← All indication landscapes